Amplitude Surgical SA Sustainability Profile
Amplitude Surgical SA, headquartered in France, is a prominent player in the orthopaedic and surgical implant industry. Founded in 2002, the company has established itself as a leader in the design and manufacture of innovative solutions for joint surgery, particularly in the fields of knee and hip arthroplasty. With a strong presence in Europe and expanding operations globally, Amplitude Surgical is renowned for its commitment to quality and precision. The company’s core products, including advanced surgical instruments and implants, are distinguished by their cutting-edge technology and ergonomic design, enhancing surgical outcomes and patient recovery. Recognised for its significant contributions to the medical field, Amplitude Surgical continues to push the boundaries of orthopaedic innovation, solidifying its market position as a trusted partner for healthcare professionals worldwide.
DitchCarbon Score
How does Amplitude Surgical SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amplitude Surgical SA's score of 50 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amplitude Surgical SA, headquartered in France, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Zydus Lifesciences Limited, which may influence its climate commitments and reporting practices. As of now, Amplitude Surgical SA has not established any documented reduction targets or climate pledges. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of its parent company, Zydus Lifesciences Limited, it is possible that Amplitude Surgical SA's climate commitments could align with broader initiatives undertaken by Zydus, although specific details are not available. The company may benefit from leveraging the sustainability frameworks and targets set by its parent organisation to enhance its own climate action efforts in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Scope 1 | 92,070,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 168,794,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Amplitude Surgical SA's Industry?
How Carbon Intensive is Amplitude Surgical SA's Location?
Amplitude Surgical SA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amplitude Surgical SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
